Global Olaparib Market Growth 2025-2031

December 2025 | 77 pages | ID: G8FB6314117EN
LP Information

Abstracts

The global Olaparib market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Olaparib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Olaparib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Olaparib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Olaparib players cover AstraZeneca, Everest Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Olaparib Industry Forecast” looks at past sales and reviews total world Olaparib sales in 2024, providing a comprehensive analysis by region and market sector of projected Olaparib sales for 2025 through 2031. With Olaparib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Olaparib industry.

This Insight Report provides a comprehensive analysis of the global Olaparib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Olaparib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Olaparib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Olaparib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Olaparib.

This report presents a comprehensive overview, market shares, and growth opportunities of Olaparib market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Tablets
• Capsules

Segmentation by Application:

• Ovarian Cancers
• Breast Cancers
• Prostate Cancers
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• AstraZeneca
• Everest Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Olaparib market?

What factors are driving Olaparib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Olaparib market opportunities vary by end market size?

How does Olaparib break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Olaparib Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Olaparib by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Olaparib by Country/Region, 2020, 2024 & 2031
2.2 Olaparib Segment by Type
  2.2.1 Tablets
  2.2.2 Capsules
2.3 Olaparib Sales by Type
  2.3.1 Global Olaparib Sales Market Share by Type (2020-2025)
  2.3.2 Global Olaparib Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Olaparib Sale Price by Type (2020-2025)
2.4 Olaparib Segment by Application
  2.4.1 Ovarian Cancers
  2.4.2 Breast Cancers
  2.4.3 Prostate Cancers
  2.4.4 Others
2.5 Olaparib Sales by Application
  2.5.1 Global Olaparib Sale Market Share by Application (2020-2025)
  2.5.2 Global Olaparib Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Olaparib Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Olaparib Breakdown Data by Company
  3.1.1 Global Olaparib Annual Sales by Company (2020-2025)
  3.1.2 Global Olaparib Sales Market Share by Company (2020-2025)
3.2 Global Olaparib Annual Revenue by Company (2020-2025)
  3.2.1 Global Olaparib Revenue by Company (2020-2025)
  3.2.2 Global Olaparib Revenue Market Share by Company (2020-2025)
3.3 Global Olaparib Sale Price by Company
3.4 Key Manufacturers Olaparib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Olaparib Product Location Distribution
  3.4.2 Players Olaparib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR OLAPARIB BY GEOGRAPHIC REGION

4.1 World Historic Olaparib Market Size by Geographic Region (2020-2025)
  4.1.1 Global Olaparib Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Olaparib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Olaparib Market Size by Country/Region (2020-2025)
  4.2.1 Global Olaparib Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Olaparib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Olaparib Sales Growth
4.4 APAC Olaparib Sales Growth
4.5 Europe Olaparib Sales Growth
4.6 Middle East & Africa Olaparib Sales Growth

5 AMERICAS

5.1 Americas Olaparib Sales by Country
  5.1.1 Americas Olaparib Sales by Country (2020-2025)
  5.1.2 Americas Olaparib Revenue by Country (2020-2025)
5.2 Americas Olaparib Sales by Type (2020-2025)
5.3 Americas Olaparib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Olaparib Sales by Region
  6.1.1 APAC Olaparib Sales by Region (2020-2025)
  6.1.2 APAC Olaparib Revenue by Region (2020-2025)
6.2 APAC Olaparib Sales by Type (2020-2025)
6.3 APAC Olaparib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Olaparib by Country
  7.1.1 Europe Olaparib Sales by Country (2020-2025)
  7.1.2 Europe Olaparib Revenue by Country (2020-2025)
7.2 Europe Olaparib Sales by Type (2020-2025)
7.3 Europe Olaparib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Olaparib by Country
  8.1.1 Middle East & Africa Olaparib Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Olaparib Revenue by Country (2020-2025)
8.2 Middle East & Africa Olaparib Sales by Type (2020-2025)
8.3 Middle East & Africa Olaparib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Olaparib
10.3 Manufacturing Process Analysis of Olaparib
10.4 Industry Chain Structure of Olaparib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Olaparib Distributors
11.3 Olaparib Customer

12 WORLD FORECAST REVIEW FOR OLAPARIB BY GEOGRAPHIC REGION

12.1 Global Olaparib Market Size Forecast by Region
  12.1.1 Global Olaparib Forecast by Region (2026-2031)
  12.1.2 Global Olaparib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Olaparib Forecast by Type (2026-2031)
12.7 Global Olaparib Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 AstraZeneca
  13.1.1 AstraZeneca Company Information
  13.1.2 AstraZeneca Olaparib Product Portfolios and Specifications
  13.1.3 AstraZeneca Olaparib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 AstraZeneca Main Business Overview
  13.1.5 AstraZeneca Latest Developments
13.2 Everest Pharmaceuticals
  13.2.1 Everest Pharmaceuticals Company Information
  13.2.2 Everest Pharmaceuticals Olaparib Product Portfolios and Specifications
  13.2.3 Everest Pharmaceuticals Olaparib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Everest Pharmaceuticals Main Business Overview
  13.2.5 Everest Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Olaparib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Olaparib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Capsules
Table 5. Global Olaparib Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Olaparib Sales Market Share by Type (2020-2025)
Table 7. Global Olaparib Revenue by Type (2020-2025) & ($ million)
Table 8. Global Olaparib Revenue Market Share by Type (2020-2025)
Table 9. Global Olaparib Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Olaparib Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Olaparib Sale Market Share by Application (2020-2025)
Table 12. Global Olaparib Revenue by Application (2020-2025) & ($ million)
Table 13. Global Olaparib Revenue Market Share by Application (2020-2025)
Table 14. Global Olaparib Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Olaparib Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Olaparib Sales Market Share by Company (2020-2025)
Table 17. Global Olaparib Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Olaparib Revenue Market Share by Company (2020-2025)
Table 19. Global Olaparib Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Olaparib Producing Area Distribution and Sales Area
Table 21. Players Olaparib Products Offered
Table 22. Olaparib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Olaparib Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Olaparib Sales Market Share Geographic Region (2020-2025)
Table 27. Global Olaparib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Olaparib Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Olaparib Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Olaparib Sales Market Share by Country/Region (2020-2025)
Table 31. Global Olaparib Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Olaparib Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Olaparib Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Olaparib Sales Market Share by Country (2020-2025)
Table 35. Americas Olaparib Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Olaparib Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Olaparib Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Olaparib Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Olaparib Sales Market Share by Region (2020-2025)
Table 40. APAC Olaparib Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Olaparib Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Olaparib Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Olaparib Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Olaparib Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Olaparib Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Olaparib Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Olaparib Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Olaparib Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Olaparib Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Olaparib Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Olaparib
Table 52. Key Market Challenges & Risks of Olaparib
Table 53. Key Industry Trends of Olaparib
Table 54. Olaparib Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Olaparib Distributors List
Table 57. Olaparib Customer List
Table 58. Global Olaparib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Olaparib Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Olaparib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Olaparib Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Olaparib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Olaparib Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Olaparib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Olaparib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Olaparib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Olaparib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Olaparib Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Olaparib Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Olaparib Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Olaparib Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. AstraZeneca Basic Information, Olaparib Manufacturing Base, Sales Area and Its Competitors
Table 73. AstraZeneca Olaparib Product Portfolios and Specifications
Table 74. AstraZeneca Olaparib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. AstraZeneca Main Business
Table 76. AstraZeneca Latest Developments
Table 77. Everest Pharmaceuticals Basic Information, Olaparib Manufacturing Base, Sales Area and Its Competitors
Table 78. Everest Pharmaceuticals Olaparib Product Portfolios and Specifications
Table 79. Everest Pharmaceuticals Olaparib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Everest Pharmaceuticals Main Business
Table 81. Everest Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Olaparib
Figure 2. Olaparib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Olaparib Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Olaparib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Olaparib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Olaparib Sales Market Share by Country/Region (2024)
Figure 10. Olaparib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTablets
Figure 12. Product Picture of Capsules
Figure 13. Global Olaparib Sales Market Share by Type in 2025
Figure 14. Global Olaparib Revenue Market Share by Type (2020-2025)
Figure 15. Olaparib Consumed in Ovarian Cancers
Figure 16. Global Olaparib Market: Ovarian Cancers (2020-2025) & (K Pcs)
Figure 17. Olaparib Consumed in Breast Cancers
Figure 18. Global Olaparib Market: Breast Cancers (2020-2025) & (K Pcs)
Figure 19. Olaparib Consumed in Prostate Cancers
Figure 20. Global Olaparib Market: Prostate Cancers (2020-2025) & (K Pcs)
Figure 21. Olaparib Consumed in Others
Figure 22. Global Olaparib Market: Others (2020-2025) & (K Pcs)
Figure 23. Global Olaparib Sale Market Share by Application (2024)
Figure 24. Global Olaparib Revenue Market Share by Application in 2025
Figure 25. Olaparib Sales by Company in 2025 (K Pcs)
Figure 26. Global Olaparib Sales Market Share by Company in 2025
Figure 27. Olaparib Revenue by Company in 2025 ($ millions)
Figure 28. Global Olaparib Revenue Market Share by Company in 2025
Figure 29. Global Olaparib Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Olaparib Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Olaparib Sales 2020-2025 (K Pcs)
Figure 32. Americas Olaparib Revenue 2020-2025 ($ millions)
Figure 33. APAC Olaparib Sales 2020-2025 (K Pcs)
Figure 34. APAC Olaparib Revenue 2020-2025 ($ millions)
Figure 35. Europe Olaparib Sales 2020-2025 (K Pcs)
Figure 36. Europe Olaparib Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Olaparib Sales 2020-2025 (K Pcs)
Figure 38. Middle East & Africa Olaparib Revenue 2020-2025 ($ millions)
Figure 39. Americas Olaparib Sales Market Share by Country in 2025
Figure 40. Americas Olaparib Revenue Market Share by Country (2020-2025)
Figure 41. Americas Olaparib Sales Market Share by Type (2020-2025)
Figure 42. Americas Olaparib Sales Market Share by Application (2020-2025)
Figure 43. United States Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Olaparib Sales Market Share by Region in 2025
Figure 48. APAC Olaparib Revenue Market Share by Region (2020-2025)
Figure 49. APAC Olaparib Sales Market Share by Type (2020-2025)
Figure 50. APAC Olaparib Sales Market Share by Application (2020-2025)
Figure 51. China Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 55. India Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Olaparib Sales Market Share by Country in 2025
Figure 59. Europe Olaparib Revenue Market Share by Country (2020-2025)
Figure 60. Europe Olaparib Sales Market Share by Type (2020-2025)
Figure 61. Europe Olaparib Sales Market Share by Application (2020-2025)
Figure 62. Germany Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 63. France Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Olaparib Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Olaparib Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Olaparib Sales Market Share by Application (2020-2025)
Figure 70. Egypt Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Olaparib Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Olaparib in 2025
Figure 76. Manufacturing Process Analysis of Olaparib
Figure 77. Industry Chain Structure of Olaparib
Figure 78. Channels of Distribution
Figure 79. Global Olaparib Sales Market Forecast by Region (2026-2031)
Figure 80. Global Olaparib Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Olaparib Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Olaparib Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Olaparib Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Olaparib Revenue Market Share Forecast by Application (2026-2031)